Aromatherapy With Lavender Essential Oil in Patients With Multiple Sclerosis

Ataturk University

Status: Active, not recruiting

Conditions: Aromatherapy; Multiple Sclerosis; Randomized Controlled Trial

Treatments: Behavioral: lavender oil

Study type: Interventional

Funder types: Other

Identifiers

NCT05929638

Esin23

Details and patient eligibility

About

The study was conducted with patients with Multiple Sclerosis (MS) who applied to the Neurology Outpatient Clinic of Atatürk University Research Hospital, met the inclusion criteria and agreed to participate in the study. At the time of the study, 96 patients were interviewed. 26 patients were excluded from the study because they did not meet the research criteria, and 70 multiple sclerosis patients constituted the research sample. 1 person from the control group and 1 person from the experimental group did not continue to work and 1 person developed a lavender allergy. The study was completed with 63 multiple sclerosis patients.

Full description

Patient Description, Fatigue Severity Scale and Pittsburgh Sleep Quality Index were applied to the patients at the first interview. Lavender oil in 15 ml opaque dark colored bottles closed with metal caps to prevent volatility to the venture group (Oleum Lavandula Angustifolia/ HACCP, Halal Food, ISO 22000:2005, ISO 14001:2015, ISO 9001:2015, ISO 45001:2018) certificates) and 40 2×2 cotton pads were delivered. Studies have reported that the most common use of aromatherapy is three drops, three days a week. Patients were asked to apply lavender oil 30 minutes before going to bed. Deep breathing increases the concentration of aromatic substances in the body. The time it takes for essential oils to be absorbed into the blood circulatory system is about 30 minutes for complete absorption by the body.

Enrollment: 70 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Being 18 years or older,
• Having been diagnosed with MS at least 1 year ago,
• Verbal communication (hearing and speaking)
• No problem with sense of smell,
• Not having an allergy to lavender,
• Having fatigue and sleep problems for the last 3 months,
• Not applying an intervention that helps to fall asleep,
• Pittsburgh Sleep Quality Index ≥5,
• Fatigue Severity Scale ≥4.

Exclusion criteria

• Having had an attack in the last month,
• Having DSM-IV Axis I disorder,
• Pregnancy,
• Using sleeping pills,
• Breastfeeding

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

70 participants in 2 patient groups

Experimental

Experimental group

Description:

Lavender oil in 15 ml opaque dark colored bottles closed with metal caps to prevent volatility to the venture group and 40 2×2 cotton pads were delivered. Patients were asked to apply lavender oil 30 minutes before going to bed. Deep breathing increases the concentration of aromatic substances in the body. The time it takes for essential oils to be absorbed into the blood circulatory system is about 30 minutes for complete absorption by the body. Information was given about dripping 3 drops of lavender oil on cotton pads and placing them 15-20 cm away from the pillow. Patients were told that they should apply lavender oil for 30 days and re-prepare the lavender oil dripped onto a new pad each night, and that the bedroom should be ventilated and free of different odors. A message was sent to the patients to remind them of the application on their phones for 30 days.

Treatment:

Behavioral: lavender oil

Control

No Intervention group

Description:

No intervention will be applied to the control group.